Displaying 1 - 1 of 1
| Active Ingredient | ROSUVASTATIN |
| Therapeutic Class | HMG-CoA REDUCTASE INHIBITORS |
| Indications | Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia)’ mixed dyslipidaemia (type Iib), or homozygous familial hypercholesterolaemia in patients who have n More ... |
| Caution | Headache, asthenia, upper respiratory infections, gastrointestinal symptoms, and myalgia have been reported; myopathy has occurred rarely . |
| Dose Range | Adult: 5-20mg once daily . Doses may be titrated to 40mg per day in those who do not meet their lipid lowering goals on 20mg per day. Doses to be increased at intervals of at least 4 weeks. See BDS supply protocols pg. 6. |
| Drug Interactions | |
| Pregnancy | Statins should be avoided in pregnancy (discontinue 3 months before attempting t More ... |
| Breast Feeding | Avoid use of rosuvastatin in lactating women. |